Tella Incorporation operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tella Incorporation with three other
companies in this sector in Japan:
Japan Tissue Engineering Company Limited
sales of 1.43 billion Japanese Yen [US$12.81 million]
of which 93%
was Regenerative Medicine Products Business),
Medinet Co., Ltd.
(1.91 billion Japanese Yen [US$17.09 million]
Trans Genic Inc
(2.29 billion Japanese Yen [US$20.50 million]
of which 48%
was CRO Business).
Tella Incorporation reported sales of ¥1.80 billion (US$16.13 million)
December of 2016.
decrease of 5.6%
versus 2015, when the company's sales were ¥1.91 billion.